247 related articles for article (PubMed ID: 10915092)
41. AIDS vaccine development: perspectives, challenges & hopes.
Excler JL
Indian J Med Res; 2005 Apr; 121(4):568-81. PubMed ID: 15817964
[TBL] [Abstract][Full Text] [Related]
42. Gene therapy as a vaccine for HIV-1.
Berkhout B; Sanders RW
Expert Opin Biol Ther; 2012 Oct; 12(10):1315-21. PubMed ID: 22803517
[TBL] [Abstract][Full Text] [Related]
43. Can HIV infection be prevented with a vaccine?
Joy AK; Dale CJ; Kent SJ
Drugs R D; 1999 Jun; 1(6):431-40. PubMed ID: 10566076
[TBL] [Abstract][Full Text] [Related]
44. Immunoreactive cycloimmunogen design based on conformational epitopes derived from human immunodeficiency virus type 1 coreceptors: cyclic dodecapeptides mimic undecapeptidyl arches of extracellular loop-2 in chemokine receptor and inhibit human immunodeficiency virus type 1 infection.
Misumi S; Takamune N; Shoji S
Endocr Metab Immune Disord Drug Targets; 2007 Jun; 7(2):141-52. PubMed ID: 17584153
[TBL] [Abstract][Full Text] [Related]
45. [Designing an effective AIDS vaccine: strategies and current status].
Coutsinos Z; Absi Z; Henin Y; Guillet JG; Launay O
Rev Med Interne; 2008 Aug; 29(8):632-41. PubMed ID: 18258341
[TBL] [Abstract][Full Text] [Related]
46. Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccines.
McBurney SP; Ross TM
Curr Pharm Des; 2007; 13(19):1957-64. PubMed ID: 17627529
[TBL] [Abstract][Full Text] [Related]
47. Current progress in the development of a prophylactic vaccine for HIV-1.
Gamble LJ; Matthews QL
Drug Des Devel Ther; 2010 Dec; 5():9-26. PubMed ID: 21267356
[TBL] [Abstract][Full Text] [Related]
48. [Vaccination against the human immunodeficiency virus].
Girard M; Pialoux G
Rev Prat; 1995 Jun; 45(12):1520-4. PubMed ID: 7660008
[TBL] [Abstract][Full Text] [Related]
49. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells.
Fultz PN; Nara P; Barre-Sinoussi F; Chaput A; Greenberg ML; Muchmore E; Kieny MP; Girard M
Science; 1992 Jun; 256(5064):1687-90. PubMed ID: 1609280
[TBL] [Abstract][Full Text] [Related]
50. [Recent advances in HIV vaccine research and development--newly unearthed challenges].
Takebe Y; Hase S; Uenishi R
Nihon Rinsho; 2010 Mar; 68(3):525-35. PubMed ID: 20229802
[TBL] [Abstract][Full Text] [Related]
51. The Maginot Line and AIDS vaccines.
Stricker RB; Goldberg B
Med Hypotheses; 1997 Jun; 48(6):527-9. PubMed ID: 9247898
[TBL] [Abstract][Full Text] [Related]
52. HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.
Hurwitz JL; Zhan X; Brown SA; Bonsignori M; Stambas J; Lockey TD; Sealy R; Surman S; Freiden P; Jones B; Martin L; Blanchard J; Slobod KS
Front Biosci; 2008 Jan; 13():609-20. PubMed ID: 17981574
[TBL] [Abstract][Full Text] [Related]
53. Quest for the AIDS vaccine.
Tonks A
BMJ; 2007 Jun; 334(7608):1346-8. PubMed ID: 17600020
[TBL] [Abstract][Full Text] [Related]
54. Subunit protein vaccines: theoretical and practical considerations for HIV-1.
Cho MW
Curr Mol Med; 2003 May; 3(3):243-63. PubMed ID: 12699361
[TBL] [Abstract][Full Text] [Related]
55. The study of elite controllers: a pure academic exercise or a potential pathway to an HIV-1 vaccine?
Blankson JN
Curr Opin HIV AIDS; 2011 May; 6(3):147-50. PubMed ID: 21399493
[No Abstract] [Full Text] [Related]
56. Preventive HIV-1 vaccines: where are we going?
Kent SJ
Int J STD AIDS; 1998 Dec; 9(12):715-9. PubMed ID: 9874116
[TBL] [Abstract][Full Text] [Related]
57. Development of a vaccine against AIDS: state of the art.
Osterhaus AD
Neth J Med; 1991 Apr; 38(3-4):93-5. PubMed ID: 1881507
[No Abstract] [Full Text] [Related]
58. The rational design of an AIDS vaccine.
Douek DC; Kwong PD; Nabel GJ
Cell; 2006 Feb; 124(4):677-81. PubMed ID: 16497577
[TBL] [Abstract][Full Text] [Related]
59. Vaccine development against HIV-1: current perspectives and future directions.
Edgeworth RL; San JH; Rosenzweig JA; Nguyen NL; Boyer JD; Ugen KE
Immunol Res; 2002; 25(1):53-74. PubMed ID: 11868934
[TBL] [Abstract][Full Text] [Related]
60. Current progress in the development of HIV vaccines.
Spearman P
Curr Pharm Des; 2006; 12(9):1147-67. PubMed ID: 16515492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
